Target- |
MechanismCell wall inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismCell wall inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with FOB Synthesis, Inc.
0 Patents (Medical) associated with FOB Synthesis, Inc.
100 Deals associated with FOB Synthesis, Inc.
100 Translational Medicine associated with FOB Synthesis, Inc.